Search

everythinglearnresearchcommunity

for

Search:↓

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

A rare ovarian tumor that produced testosterone caused a blood clot in the lungs and increased red blood cells in a woman.

Classical PCOS types A and B are most common and linked to higher health risks.

The method effectively detects banned substances in urine for sports antidoping.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Women with acne have lower levels of a specific hormone marker than women without acne.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.